ArticleRadiology case reports2026
Adenoid cystic carcinoma of the breast: A rare manifestation of a rare malignancy.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenoid cystic carcinoma (ACC) is a rare malignancy most commonly arising from the salivary glands. It less frequently manifests in other glandular tissues, including the breast, lacrimal glands, and the trachea. ACC is characterized by slow growth, yet exhibits locally aggressive behavior and propensity for late recurrence. Despite its local aggressiveness, the overall prognosis for primary breast manifestations of ACC is generally favorable. Mammographic and sonographic appearances often demonstrate an indistinctly marginated mass of variable shape and size. MRI findings are similarly variable, often demonstrating a lobulated or spiculated mass with variable patterns and kinetics of enhancement. As such, histopathological and immunohistochemical analysis are necessary for definitive diagnosis. In the breast, the mainstay treatment is lumpectomy or mastectomy with or without sentinel lymph node biopsy and post-operative radiation therapy. We present the case of a 61-year-old female patient with a high risk for breast malignancy who was found to have enhancing masses on a screening MRI of the breasts. Ultrasound-guided biopsy yielded a histopathological finding of ACC. Positive margins were identified on surgical pathology following lumpectomy and subsequent nipple-sparing mastectomy. This case demonstrates a rare exception to the tendency of radiographically smaller ACC masses to correlate with lower rates of disease persistence refractory to treatment, wherein a mammographically occult tumor with apparently limited disease on MRI produced multiple postsurgical finings of positive margins, necessitating multiple stages of excision and adjuvant radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.